Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations. Issue 5 (7th September 2021)

• Record Type: Journal Article
• Authors: Qin, Qi; Wei, Cuibai; Piao, YueShan; Lian, Fang; Wu, Hao; Zhou, Aihong; Wang, Fen; Zuo, Xiumei; Han, Yue; Lyu, Jihui; Guo, Dongmei; Jia, Jianping
• Is Part Of: Neurologist. Volume 26:Issue 5(2021)
• Page Start: 189
• Page End: 195
• Publication Date: 2021-09-07
• Subjects: leptomeningeal amyloidosis -- transthyretin -- leptomeningeal enhancement -- TTR mutations; Nervous System Diseases -- Periodicals; Nervous system -- Diseases -- Periodicals; Neurologie; 616.8
• DOI: 10.1097/NRL.0000000000000337
• Languages: English
• ISSNs: 1074-7931

Abstract

Abstract : Introduction: Leptomeningeal amyloidosis (LA) represents a rare subtype of familial transthyretin (TTR) amyloidosis, characterized by deposition of amyloid in cranial and spinal leptomeninges. Of >120 TTR mutations identified, few have been associated with LA. Case Report: A 27-year-old male presented with a 2-year history of progressive symptoms including cognitive decline and right-sided weakness and numbness. Cerebrospinal fluid (CSF) analyses demonstrated high protein level. Gadolinium-enhanced magnetic resonance imaging (MRI) revealed extensive leptomeningeal enhancement over the surface of the brain and spinal cord. Pathologic analyses revealed a TTR mutation c.113A>G (p.D38G). Review Summary: Fifteen mutations and genotype-phenotype correlation of 72 LA patients have been summarized to provide an overview of LA associated with transthyretin mutations. The mean age of clinical onset was 44.9 years and the neurological symptoms primarily included cognitive impairment, headache, ataxia seizures and hearing, visual loss. CSF analysis showed elevated high CSF protein level and MRI revealed extensive leptomeningeal enhancement. Conclusion: Clinicians should be aware of this rare form of familial transthyretin amyloidosis as well as its typical MRI enhancement and high CSF protein. The important role of biopsy, genetic testing and the potential early diagnosis value of contrast MRI were suggested. Early recognition of these characteristics is important to provide misdiagnosis and shorten the time before correct diagnosis. These findings expand the phenotypic spectrum of TTR gene and have implications for the diagnosis, treatment, and systematic study of LA.